136 related articles for article (PubMed ID: 33788127)
1. AICAR suppresses cell proliferation and synergizes with decitabine in myelodysplastic syndrome via DNA damage induction.
Liu J; Liang L; Li X; Peng YL; Zhang J; Wang XL; Liu J; Nie L
Biotechnol Lett; 2021 Jun; 43(6):1131-1142. PubMed ID: 33788127
[TBL] [Abstract][Full Text] [Related]
2. AICAR induces mitochondrial apoptosis in human osteosarcoma cells through an AMPK-dependent pathway.
Morishita M; Kawamoto T; Hara H; Onishi Y; Ueha T; Minoda M; Katayama E; Takemori T; Fukase N; Kurosaka M; Kuroda R; Akisue T
Int J Oncol; 2017 Jan; 50(1):23-30. PubMed ID: 27878239
[TBL] [Abstract][Full Text] [Related]
3. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
4. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
[TBL] [Abstract][Full Text] [Related]
5. DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes.
Kayamori K; Nagai Y; Zhong C; Kaito S; Shinoda D; Koide S; Kuribayashi W; Oshima M; Nakajima-Takagi Y; Yamashita M; Mimura N; Becker HJ; Izawa K; Yamazaki S; Iwano S; Miyawaki A; Ito R; Tohyama K; Lennox W; Sheedy J; Weetall M; Sakaida E; Yokote K; Iwama A
Blood Adv; 2021 Jan; 5(2):438-450. PubMed ID: 33496740
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
Theodoropoulou S; Kolovou PE; Morizane Y; Kayama M; Nicolaou F; Miller JW; Gragoudas E; Ksander BR; Vavvas DG
FASEB J; 2010 Aug; 24(8):2620-30. PubMed ID: 20371623
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
Rattan R; Giri S; Singh AK; Singh I
J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
[TBL] [Abstract][Full Text] [Related]
9. Decitabine shows synergistic effects with arsenic trioxide against myelodysplastic syndrome cells via endoplasmic reticulum stress-related apoptosis.
Huang L; Liu Z; Jiang H; Li L; Fu R
J Investig Med; 2019 Oct; 67(7):1067-1075. PubMed ID: 30898879
[TBL] [Abstract][Full Text] [Related]
10. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
[TBL] [Abstract][Full Text] [Related]
11. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
[TBL] [Abstract][Full Text] [Related]
12. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase.
Sauer H; Engel S; Milosevic N; Sharifpanah F; Wartenberg M
Int J Oncol; 2012 Feb; 40(2):501-8. PubMed ID: 22002081
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
14. The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.
Kim WG; Choi HJ; Kim TY; Shong YK; Kim WB
Korean J Intern Med; 2014 Jul; 29(4):474-81. PubMed ID: 25045295
[TBL] [Abstract][Full Text] [Related]
15. AICAR and Decitabine Enhance the Sensitivity of K562 Cells to Imatinib by Promoting Mitochondrial Activity.
Zhu XY; Liu W; Liang HT; Tang L; Zou P; You Y; Zhu XJ
Curr Med Sci; 2020 Oct; 40(5):871-878. PubMed ID: 33123902
[TBL] [Abstract][Full Text] [Related]
16. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
[TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and glucose deprivation by down-regulating phospho-retinoblastoma protein and cyclin D.
Zang Y; Yu LF; Nan FJ; Feng LY; Li J
J Biol Chem; 2009 Mar; 284(10):6175-84. PubMed ID: 19144636
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibitory effect of Smo inhibitor jervine and its combination with decitabine can target Hedgehog signaling pathway to inhibit myelodysplastic syndrome cell line.
Zhao F; Wang J; Yao L; Qin YT; Tuerxun N; Wang H; Jiang M; Hao JP
Hematology; 2021 Dec; 26(1):518-528. PubMed ID: 34314648
[TBL] [Abstract][Full Text] [Related]
19. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.
Ishii N; Matsumura T; Kinoshita H; Motoshima H; Kojima K; Tsutsumi A; Kawasaki S; Yano M; Senokuchi T; Asano T; Nishikawa T; Araki E
J Biol Chem; 2009 Dec; 284(50):34561-9. PubMed ID: 19843515
[TBL] [Abstract][Full Text] [Related]
20. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]